Início › Doença de Alzheimer › Flórida › The Villages
Ensaios clínicos de Doença de Alzheimer em The Villages, FL
15 estudos para Doença de Alzheimer estão buscando participantes em locais em The Villages e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
RecrutandoFase 1Voluntários saudáveis bem-vindos
- Local Institution - 0006, The Villages
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
RecrutandoFase 2
- Charter Research - Lady Lake- Site Number : 8400004, The Villages
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecrutandoFase 3
- Charter Research, The Villages
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecrutandoFase 3
- Charter Research - Lady Lake/The Villages, The Villages
- K2 Medical Research - The Villages, Lady Lake · a 3 mi de distância
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
RecrutandoFase 1/2
- K2 Medical Research - The Villages /ID# 278290, Lady Lake · a 3 mi de distância
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecrutandoFase 3
- Local Institution - 0129, The Villages
- K2 MEDICAL Research THE VILLAGES, Lady Lake · a 3 mi de distância
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecrutandoFase 2
- Charter Research - Lady Lake, The Villages
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecrutandoFase 2
- Charter Research - Lady Lake ( Site 1019), The Villages
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecrutandoFase 1
- Charter Research, LLC, The Villages
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecrutandoFase 3
- Charter Research - Lady Lake, The Villages
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
RecrutandoFase 1/2
- Charter Research, LLC, The Villages
- K2 Medical Research The Villages LLC, Lady Lake · a 3 mi de distância
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecrutandoFase 3
- Charter Research - The Villages, The Villages
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RecrutandoFase 2
- Charter Research The Villages, The Villages
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
RecrutandoFase 1Voluntários saudáveis bem-vindos
- K2 Medical Research - The Villages, Lady Lake · a 3 mi de distância
[18F]PI-2620 Phase 3 Histopathological Study
RecrutandoFase 3
- K2 Medical Research, Lady Lake · a 3 mi de distância
Ensaios de Doença de Alzheimer em outras cidades
- Boston, MA26 estudos
- Orlando, FL25 estudos
- St. Louis, MO22 estudos
- New York City, NY21 estudos
- Miami, FL20 estudos
- Tampa, FL17 estudos
- Atlanta, GA16 estudos
- Philadelphia, PA15 estudos
- Phoenix, AZ15 estudos
- Indianapolis, IN14 estudos
- Los Angeles, CA14 estudos
- West Palm Beach, FL13 estudos
Outros estudos em The Villages
- Obesidade9 estudos
- Sobrepeso8 estudos
- Demência6 estudos
- Comprometimento Cognitivo Leve4 estudos
- Doença Hepática Esteatótica3 estudos
- Doença de Parkinson3 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.